Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BEATRICE COMMUNITY HOSPITAL & HEALTH CENTER INC

NPI: 1184642894 · BEATRICE, NE 68310 · Critical Access Hospital · NPI assigned 07/18/2006

$10.42M
Total Medicaid Paid
203,355
Total Claims
163,961
Beneficiaries
166
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHARALDSON, RICK (CEO)
NPI Enumeration Date07/18/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,960 $1.27M
2019 27,150 $1.24M
2020 27,297 $1.31M
2021 47,126 $2.43M
2022 51,370 $2.63M
2023 20,716 $1.17M
2024 4,736 $350K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 11,772 10,310 $1.75M
74177 Computed tomography, abdomen and pelvis; with contrast material 406 371 $550K
99284 Emergency department visit for the evaluation and management, high severity 3,560 2,810 $511K
80053 Comprehensive metabolic panel 12,037 10,251 $461K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14,779 12,121 $417K
70450 Computed tomography, head or brain; without contrast material 697 643 $351K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,042 2,655 $296K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5,586 1,724 $244K
71046 Radiologic examination, chest; 2 views 2,352 2,143 $227K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,047 1,874 $216K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3,973 3,809 $212K
J3490 Unclassified drugs 6,795 3,354 $189K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,863 1,226 $188K
84443 Thyroid stimulating hormone (TSH) 3,848 3,697 $183K
36415 Collection of venous blood by venipuncture 18,356 14,547 $180K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 718 595 $157K
87631 2,008 1,882 $152K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5,466 4,351 $137K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,638 1,999 $137K
96375 Therapeutic injection; each additional sequential IV push 2,003 1,639 $136K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,502 2,139 $133K
71045 Radiologic examination, chest; single view 1,594 1,423 $126K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,221 1,870 $105K
84484 2,040 1,574 $103K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 159 148 $102K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,591 630 $97K
80048 Basic metabolic panel (calcium, ionized) 3,484 2,922 $95K
87660 2,095 1,982 $92K
87510 2,267 2,144 $92K
87480 2,267 2,144 $92K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,976 1,672 $92K
96361 Intravenous infusion, hydration; each additional hour 2,952 2,208 $90K
74176 Computed tomography, abdomen and pelvis; without contrast material 68 62 $90K
87086 Culture, bacterial; quantitative colony count, urine 3,602 3,291 $86K
G0378 Hospital observation service, per hour 125 106 $82K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,773 1,532 $82K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 746 260 $77K
80061 Lipid panel 2,996 2,916 $77K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 428 400 $73K
J7030 Infusion, normal saline solution , 1000 cc 3,038 2,295 $67K
81003 5,722 5,090 $65K
83036 Hemoglobin; glycosylated (A1C) 3,023 2,935 $64K
84145 1,882 1,458 $63K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 719 583 $63K
59025 Fetal non-stress test 473 242 $62K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,681 1,077 $59K
J8499 Prescription drug, oral, non chemotherapeutic, nos 6,129 3,023 $56K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,923 1,893 $52K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 755 276 $51K
73630 431 401 $51K
83690 1,359 1,223 $50K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,300 1,232 $50K
J7120 Ringers lactate infusion, up to 1000 cc 1,595 1,065 $48K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 706 568 $46K
77067 Screening mammography, bilateral, including computer-aided detection 445 441 $42K
81001 2,744 2,487 $39K
97161 896 862 $38K
J3010 Injection, fentanyl citrate, 0.1 mg 677 598 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 671 588 $35K
99281 Emergency department visit for the evaluation and management, self-limited or minor 470 434 $33K
83605 1,533 1,247 $33K
87428 778 751 $32K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,005 985 $32K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 999 980 $32K
81025 1,769 1,695 $31K
J2704 Injection, propofol, 10 mg 712 620 $31K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 205 190 $29K
0099U 118 115 $29K
83880 677 563 $28K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 637 554 $28K
85027 1,523 1,391 $28K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 99 99 $25K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 625 190 $23K
83735 887 641 $20K
76830 Ultrasound, transvaginal 78 78 $20K
74018 151 137 $20K
73610 157 142 $18K
84702 333 195 $18K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 651 635 $17K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 204 177 $16K
84439 959 904 $15K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 112 42 $14K
85610 1,074 838 $14K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 142 136 $14K
80306 389 349 $14K
86703 330 322 $13K
87040 1,076 504 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete 37 37 $13K
73030 126 106 $12K
86140 760 682 $11K
80055 62 61 $11K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 111 90 $10K
73562 95 89 $10K
83550 371 358 $10K
96376 157 115 $10K
83655 289 285 $10K
83540 394 377 $9K
72125 Computed tomography, cervical spine; without contrast material 12 12 $8K
J2270 Injection, morphine sulfate, up to 10 mg 164 147 $8K
85018 590 559 $8K
77063 Screening digital breast tomosynthesis, bilateral 247 245 $8K
82728 358 348 $8K
85379 244 219 $7K
85652 399 367 $6K
J2250 Injection, midazolam hydrochloride, per 1 mg 154 137 $6K
J1170 Injection, hydromorphone, up to 4 mg 145 88 $6K
84703 530 484 $5K
73110 59 53 $5K
82570 241 227 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 110 109 $5K
82607 259 246 $4K
J7050 Infusion, normal saline solution, 250 cc 569 284 $4K
82043 130 126 $4K
87420 136 125 $3K
80320 74 64 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 204 176 $3K
73502 30 27 $3K
80050 General health panel 25 25 $3K
86850 57 51 $2K
87808 159 153 $2K
73130 32 25 $2K
87070 75 66 $2K
J0690 Injection, cefazolin sodium, 500 mg 16 12 $2K
82962 559 265 $2K
87486 114 110 $2K
87581 113 109 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 24 24 $2K
86901 59 52 $2K
85730 46 43 $2K
J2550 Injection, promethazine hcl, up to 50 mg 26 24 $2K
87653 24 24 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 95 92 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 17 17 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 38 37 $1K
86900 58 52 $1K
87205 92 81 $1K
73564 12 12 $1K
87075 70 62 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 26 15 $1K
74019 13 13 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 15 14 $1K
82803 14 13 $956.36
82950 43 43 $925.11
J0696 Injection, ceftriaxone sodium, per 250 mg 18 15 $861.92
A9270 Non-covered item or service 163 103 $777.71
36416 254 238 $769.26
97165 14 12 $690.63
84481 17 14 $545.60
84153 13 13 $502.40
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 240 202 $500.45
84156 16 13 $492.42
87340 13 12 $308.76
86803 17 16 $287.25
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 24 24 $275.00
86141 31 28 $238.49
86592 15 14 $232.26
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 33 29 $217.18
87430 12 12 $141.00
84100 15 13 $116.06
82565 13 12 $104.06
82044 24 24 $99.81
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 13 13 $55.92
J7060 5% dextrose/water (500 ml = 1 unit) 19 12 $5.22
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 18 12 $0.22
3044F 786 766 $0.03
3051F 14 12 $0.00